Articles tagged with "AS Resource Center"

FDA Approves Upadacitinib for Non-Radiographic Axial Spondyloarthritis

October 27, 2022 • By Michele B. Kaufman, PharmD, BCGP

Sacroiliitis on MRI: axSpA or Another Cause?

August 31, 2022 • By Arthritis & Rheumatology

Data Accumulate to Suggest HLA-B27 Status May Drive Axial Phenotype in SpA

May 20, 2022 • By Lara C. Pullen, PhD

Common Misconceptions Clarified: Ankylosing Spondylitis & Non-Radiographic Axial Spondyloarthritis

March 23, 2022 • By Jason Liebowitz, MD

Andrew Brookes / Image Source on Offset

Clinical Insights into Axial Spondyloarthritis: Rheumatology Drugs at a Glance, Part 5

February 10, 2022 • By Mary Choy, PharmD, BCGP, FASHP

Care of Patients with Spondyloarthritis

December 9, 2021 • By Lara C. Pullen, PhD

The Big Picture: How to Assess Disease Activity in Patients with axSpA & PsA in Clinical Practice

December 2, 2021 • By Mary Beth Nierengarten

Early & Long-Term Remission of Spondyloarthritis

July 16, 2021 • By Jason Liebowitz, MD

Cytokine Targets & Treatment Developments for Psoriatic Arthritis & Spondyloarthritis

March 15, 2021 • By Carina Stanton

MRI & Axial Spondyloarthritis: Experts Discuss Controversies in the Diagnostic Evaluation of axSpA

January 25, 2021 • By Lara C. Pullen, PhD